The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, a unique instrument for quantitative phase imaging based on holographic microscopy.
The Q-Phase microscope is a one-of-a-kind holographic microscope capable of imaging live cells for up to five days. Traditional light microscopy of cells requires staining and chemical treatments that capture the state of the cell in time but kills the cell in the process. This new technology allows cells to be imaged while living over the course of days.
“The partnership with TESCAN affords the University the ability to gather cutting-edge data from the latest high-tech equipment” said Dr. Paul Eason, UNF-MSERF director and associate professor of mechanical engineering in the College of Computing, Engineering and Construction.
The agreement between the University and TESCAN provides UNF the opportunity to house brand new and unique microscopes for the purpose of instrument validation and demonstration for potential users. The Q-Phase microscope, housed at MSERF in the newly renovated Skinner-Jones Hall, is on the UNF campus for a 90-day trial installation.
Researchers both at UNF and the Mayo Clinic are taking advantage of the trial installation and utilizing the high-powered device in their respective studies of treating various types of cancer.
Image Credit: AZO Nano
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]